Word: antacid
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
Around the world, drug companies are teaming up in search of success. Britain's Beecham Group, purveyor of Tums antacid and Brylcreem hair lotion, last month merged with Philadelphia's SmithKline Beckman, developer of the antiulcer drug Tagamet, in a deal that will create the No. 2 pharmaceutical company after Merck. American Home Products, the maker of Advil and Anacin, is acquiring A.H. Robins. Merck, meanwhile, is scarcely standing still. In March the company formed a joint venture with Johnson & Johnson, its New Jersey neighbor, under which Merck will develop over-the-counter versions of patented medicines that Johnson & Johnson...
Tums, meet Tagamet. The race to create global pharmaceutical companies inspired a transatlantic merger last week. London's Beecham Group, maker of Tums antacid, and Philadelphia's SmithKline Beckman, developer of the anti- ulcer drug Tagamet, said they will form a company with more than $6.7 billion in total sales. The merged corporation, to be renamed SmithKline Beecham, will rank No. 2 in the pharmaceutical world to New Jersey-based Merck...
...volatile Democratic contest, in particular, is straight out of an antacid commercial. No candidate has much margin for error: one gaffe, one stumble, one strategic miscue could spell the difference between heartburn and heartthrob. With a tightly bunched field and estimates of turnout as low as 90,000 Democrats, the support of a few thousand caucus attendees may be all that separates the victor from also-ran status. The latest political tout sheets label Richard Gephardt as the freckle-faced favorite; he put on last week's most elaborately choreographed media event, importing 42 House colleagues to stand with...
...through New Year's Day, the contestants kept raising the ante. American Home Products, the maker of Anacin headache tablets, reportedly offered $3.08 billion, as Sanofi did. But A.H.P. wanted all of Robins, while Sanofi was content with 58%. The last announced bid from Rorer, the manufacturer of Maalox antacid, was valued at $2.98 billion...
Richardson-Vicks, which sells such popular products as NyQuil cough syrup and Clearasil acne cream, agreed to sell out to Procter & Gamble for $1.24 billion and thus avoid a bid from Unilever. Revlon, which markets items ranging from Charlie perfume to Tums antacid tablets, eluded Pantry Pride by accepting a buy-out offer of about $1.7 billion from Forstmann Little. If the deals go through, Richardson-Vicks and Revlon will join General Foods (Jell-O, Maxwell House coffee) and Nabisco (Oreo cookies, Ritz crackers) on the list of consumer-goods titans being taken over this year...